Efficacy of open‐label counterconditioning for reducing nocebo effects on pressure pain
European Journal of Pain · 2023-08 · 27 (7) · 831-847
DOI: 10.1002/ejp.2112 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Pain, online erschienen am 03.04.2023. Verfasst von Simone Meijer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Health, Medical and Neuropsychology Unit, Leiden University, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Chronic Pain, Musculoskeletal Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Nocebo effects can adversely affect the experience of physical symptoms, such as pain and itch. Nocebo effects on itch and pain have shown to be induced by conditioning with thermal heat stimuli and reduced by counterconditioning. However, open‐label counterconditioning, in which participants are informed about the placebo content of the treatment, has not been investigated, while this can be highly relevant for clinical practice. Furthermore, (open‐label) conditioning and counterconditioning has not been investigated for pain modalities relevant to musculoskeletal disorders, such as pressure pain.
Methods
In a randomized controlled trial, we investigated in 110 healthy female participants whether nocebo effects on pressure pain combined with open‐label verbal suggestions can be (1) induced via conditioning and (2) reduced via counterconditioning. Participants were allocated to either a nocebo‐ or sham‐conditioning group. Next, the nocebo group was allocated to either counterconditioning, extinction or continued nocebo conditioning; sham conditioning was followed by placebo conditioning.
Results
Nocebo effects were significantly larger after nocebo conditioning than sham conditioning ( d = 1.27). Subsequently, a larger reduction of the nocebo effect was found after counterconditioning than after extinction ( d = 1.02) and continued nocebo conditioning ( d = 1.66), with effects similar to placebo conditioning (following sham conditioning).
Conclusions
These results show that (counter)conditioning combined with open‐label suggestions can modulate nocebo effects on pressure pain, which provides promise in designing learning‐based treatments to reduce nocebo effects in patients with chronic pain disorders, particularly for musculoskeletal disorders. Significance Few studies have investigated the efficacy counterconditioning to reduce nocebo effects. Whereas typically deceptive procedures are used, these are not ethically appropriate for use in clinical practice. The current study demonstrates that open‐label counterconditioning in a pain modality relevant for many chronic pain conditions may be a promising new strategy for reducing nocebo effects in a non‐deceptive and ethical manner, which provides promise in designing learning‐based treatments to reduce nocebo effects in patients with chronic pain disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Health, Medical and Neuropsychology Unit, Leiden University, Leiden, The Netherlands.
- Leiden Institute for Brain and Cognition (LIBC), Leiden, The Netherlands.
- Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
- Medical Delta, Erasmus University Rotterdam, Leiden University and Delft University of Technology, Rotterdam/Leiden/Delft, The Netherlands.
- Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands.
ORCID-Profile: Simone Meijer
Zitieren
APA
Meijer, S., Karacaoglu, M., van Middendorp, H., Veldhuijzen, D. S., Jensen, K. B., Peerdeman, K. J., & Evers, A. W. M. (2023). Efficacy of open‐label counterconditioning for reducing nocebo effects on pressure pain. European Journal of Pain, 27(7), 831-847. https://doi.org/10.1002/ejp.2112
Vancouver
Meijer S, Karacaoglu M, van Middendorp H, Veldhuijzen DS, Jensen KB, Peerdeman KJ, et al. Efficacy of open‐label counterconditioning for reducing nocebo effects on pressure pain. European Journal of Pain. 2023;27(7):831-847. doi:10.1002/ejp.2112
BibTeX
@article{Meijer2023,
author = {Meijer, Simone and Karacaoglu, Merve and van Middendorp, Henriët and Veldhuijzen, Dieuwke S and Jensen, Karin B and Peerdeman, Kaya J and Evers, Andrea W M},
title = {Efficacy of open‐label counterconditioning for reducing nocebo effects on pressure pain},
journal = {European Journal of Pain},
year = {2023},
volume = {27},
number = {7},
pages = {831--847},
doi = {10.1002/ejp.2112}
}
EUVIMED